Madrigal Pharmaceuticals, Inc.MDGLNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank93
3Y CAGR-4.9%
5Y CAGR+24.8%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
-4.9%/yr
vs +63.8%/yr prior
5Y CAGR
+24.8%/yr
Recent deceleration
Acceleration
-68.7pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
3x
Strong expansion
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 21.68 | +149.1% |
| 2024 | 8.70 | -18.4% |
| 2023 | 10.67 | -57.7% |
| 2022 | 25.20 | +252.7% |
| 2021 | 7.15 | -0.2% |
| 2020 | 7.16 | +112.5% |
| 2019 | 3.37 | -3.7% |
| 2018 | 3.50 | -43.3% |
| 2017 | 6.17 | +189.5% |
| 2016 | 2.13 | - |